A detailed history of Jpmorgan Chase & CO transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 375,268 shares of LNTH stock, worth $41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
375,268
Previous 568,873 34.03%
Holding current value
$41 Million
Previous $35.4 Million 14.9%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$58.87 - $83.05 $11.4 Million - $16.1 Million
-193,605 Reduced 34.03%
375,268 $30.1 Million
Q1 2024

May 10, 2024

BUY
$51.07 - $68.26 $1.83 Million - $2.44 Million
35,782 Added 6.71%
568,873 $35.4 Million
Q4 2023

Feb 12, 2024

BUY
$55.6 - $77.89 $795,469 - $1.11 Million
14,307 Added 2.76%
533,091 $33.1 Million
Q3 2023

Nov 14, 2023

BUY
$60.27 - $90.75 $8.21 Million - $12.4 Million
136,270 Added 35.62%
518,784 $36 Million
Q2 2023

Aug 11, 2023

BUY
$82.41 - $99.65 $3.5 Million - $4.23 Million
42,486 Added 12.49%
382,514 $32.1 Million
Q1 2023

May 18, 2023

BUY
$47.76 - $82.86 $8.15 Million - $14.1 Million
170,659 Added 100.76%
340,028 $28.1 Million
Q1 2023

May 11, 2023

SELL
$47.76 - $82.86 $6.9 Million - $12 Million
-144,415 Reduced 46.02%
169,369 $14 Million
Q4 2022

Feb 13, 2023

BUY
$48.76 - $77.67 $60,169 - $95,844
1,234 Added 0.39%
313,784 $16 Million
Q3 2022

Nov 14, 2022

BUY
$61.42 - $86.29 $3.38 Million - $4.75 Million
54,993 Added 21.35%
312,550 $22 Million
Q2 2022

Aug 11, 2022

BUY
$55.54 - $72.65 $1.07 Million - $1.4 Million
19,301 Added 8.1%
257,557 $17 Million
Q1 2022

May 11, 2022

SELL
$24.28 - $56.64 $183,556 - $428,198
-7,560 Reduced 3.08%
238,256 $13.2 Million
Q4 2021

Feb 10, 2022

SELL
$22.54 - $30.44 $1.03 Million - $1.39 Million
-45,639 Reduced 15.66%
245,816 $7.1 Million
Q3 2021

Nov 12, 2021

BUY
$24.23 - $28.59 $7.06 Million - $8.33 Million
291,455 New
291,455 $7.49 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $7.52B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.